Showing 4591-4600 of 5623 results for "".
- Katena Products Announces Steve Blazejewski as New CEOhttps://modernod.com/news/katena-products-announces-steve-blazejewski-as-new-ceo/2478633/Katena Products announced that Steve Blazejewski has joined as Chief Executive Officer. As a seasoned executive, Mr. Blazejewski brings impressive leadership experience and medical device knowledge to Katena. He has previously served as President of Medical Solutions at Cardinal Health and
- President-Elect Biden Picks California Attorney General to Lead HHShttps://modernod.com/news/president-elect-biden-picks-california-attorney-general-to-lead-hhs/2478630/President-elect Joe Biden plans to nominate California Attorney General Xavier Becerra to lead the Department of Health and Human Services (HHS), according to
- Effort To ‘End Blindness’ Marks Milestone With Leading Scientists Recognized For Pioneering Workhttps://modernod.com/news/effort-to-end-blindness-marks-milestone-with-leading-scientists-recognized-for-pioneering-work/2478623/End Blindness 2020, a joint effort by leading scientists and figures from the worlds of business, politics, culture, art, music and entertainment to rid the world of blindness, is about to mark a milestone. On December 14, 2020, 13 scientists will share
- Focus Vision Supplements Now Offer Eyelid Products to Soothe Dry Eye and Aid in Postoperative Healinghttps://modernod.com/news/focus-vision-supplements-now-offer-eyelid-products-to-soothe-dry-eye-and-aid-in-postoperative-healing/2478622/Covalent Medical, owner of Focus Vision Supplements, has developed two new products to aid in pre/postoperative care and soothe the symptoms of occasional dry eye and blepharitis. Focus Eyelid Scrub Formula is a preservative-free, deep-cleaning foam eyelid cleanser
- Market Scope: Cornea Products Market to Grow an Estimated 6.1 Percent Through 2025https://modernod.com/news/market-scope-cornea-products-market-to-grow-an-estimated-6-1-percent-through-2025/2478618/Expanding use of products to treat many corneal diseases will increase the role of devices and surgery in the cornea treatment landscape, according to Market Scope. Over 1 billion people are affected by 50 corneal diseases that cause cornea impairment, including corneal ectasias, dystrophies, ker
- Medicare Cuts Jeopardize Patient Care and Ignore Impacts of Pandemichttps://modernod.com/news/medicare-cuts-jeopardize-patient-care-and-ignore-impacts-of-pandemic/2478611/The Medicare Physician Fee Schedule (MPFS) final rule released today by the Centers for Medicare & Medicaid Services (CMS) will harm patients and further destabilize a health care system already under severe strain from the pandemic, according to a Surgical Care Coalition news release.
- UK Authorizes Use of Pfizer, BioNTech’s COVID-19 Vaccinehttps://modernod.com/news/uk-authorizes-use-of-pfizer-biontechs-covid-19-vaccine/2478614/The UK government said Wednesday that it accepted a recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to grant temporary authorization of Pfizer and BioNTech’s mRNA-based COVID-19 vaccine BNT162b2. A Department of Health and Social Care spokesperson said 
- ViGeneron and WuXi Advanced Therapies Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapyhttps://modernod.com/news/vigeneron-and-wuxi-advanced-therapies-enter-strategic-manufacturing-partnership-for-next-generation-ophthalmic-gene-therapy/2478606/ViGeneron and WuXi Advanced Therapies announced a partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program. ViGeneron’s gene therapy pipeline addresses ophthalmic diseases with high unmet medical needs. Its lead pro
- New Survey Finds Critical Need for Education on Cataracts and Modern Treatment Optionshttps://modernod.com/news/new-survey-finds-critical-need-for-education-on-cataracts-and-modern-treatment-options/2478601/Johnson & Johnson Vision announced findings from a new survey that assessed awareness of cataracts among adults around the world. Cataracts are the leading cause of blindness globally,[1] with more than 90% of people developing cataracts by age
- Heidelberg Engineering Names New Scientific Directorhttps://modernod.com/news/heidelberg-engineering-names-new-scientific-director/2478603/Charles Reisman has joined Heidelberg Engineering’s global management team as Scientific Director. In this newly created role, he will be responsible for the clinical research plan that directly feeds into the product development pipeline. Mr. Reisman is an accomplished clinical validation